Business Context and Reporting Period
This Form 8-K filing by International Money Express, Inc. (IMXI) covers events occurring on April 25, 2019, and April 29, 2019. The report details the conclusion of a tender offer for outstanding warrants, the approval of a warrant amendment, and the closing of an incremental term loan.
Key Financial Metrics and Capital Structure
- Debt Financing: The Company closed an Incremental Term Loan of $12,000,000 on April 29, 2019.
- Total Term Loan Outstanding: Approximately $100,875,000 following the incremental funding.
- Warrant Exchange Cash Consideration: Approximately $9,986,440.80 to be paid for tendered warrants.
- Equity Issuance: An aggregate of 1,792,193 shares of Common Stock expected to be issued for tendered warrants.
- Post-Issuance Share Count: Approximately 37,974,976 shares of Common Stock outstanding (excluding potential shares from forced conversion of remaining warrants).
Material Changes and Events
- Warrant Tender Offer Completion: The offer expired on April 25, 2019. A total of 8,916,465 warrants (approximately 99.51% of outstanding warrants) were validly tendered.
- Warrant Amendment Approval: Consents were received from holders of more than 65% of outstanding warrants, approving Amendment No. 1 to the Warrant Agreement. This amendment permits the Company to force the conversion of remaining untendered warrants into 0.181 shares of Common Stock and $1.00 in cash per warrant.
- Forced Conversion Intent: The Company intends to exchange all remaining untendered warrants on or about May 20, 2019, though it is not legally required to do so.
- Use of Proceeds: Proceeds from the $12 million Incremental Term Loan will fund the cash portion of the warrant exchange, offer-related expenses, and working capital.
Outlook, Risks, and Management Commentary
- Management Intent: Management plans to utilize the new debt facility to settle the cash obligations associated with the warrant exchange.
- Uncertainty on Forced Conversion: While the Company intends to force the conversion of remaining warrants, the filing explicitly states there is no assurance that it will exercise this right.
- Debt Terms: The incremental loan is subject to the same interest rate and terms as the existing term loan under the Credit Agreement dated November 7, 2018.
Investor Verification Checklist
- Verify the final settlement date for the cash portion of the warrant exchange (expected May 20, 2019).
- Confirm whether the Company exercises its right to force-convert the remaining ~0.49% of untendered warrants.
- Review the specific interest rate and repayment schedule details in the Increase Joinder No. 1 (Exhibit 10.2).
- Monitor the impact of the 1,792,193 new shares on earnings per share (EPS) dilution.